Kamran Alam is Executive Vice President, Finance and Chief Financial Officer of Notch Therapeutics. Prior to joining Notch, he served as Interim Chief Financial Officer of Neoleukin Therapeutics, Inc. following Neoleukin’s merger in 2019 with Aquinox Pharmaceuticals, Inc.. Previously, in his role as Chief Financial Officer and Vice President, Finance at Aquinox, Mr. Alam provided finance leadership for the company’s IPO on the NASDAQ stock exchange in 2014. Prior to his tenure with Aquinox, Mr. Alam held senior roles in business development for a number of biotechnology and pharmaceutical companies. Mr. Alam is a Chartered Professional Accountant. He holds a B.Sc. in Cell Biology and Genetics from the University of British Columbia and an M.B.A. in International Business and Strategy from the University of Victoria.

• 

  Executive Vice President, Finance in Notch Therapeutics

  Notch is building best-in-class T cell therapies.

• 

  CFO: Chief Financial Officer in Notch Therapeutics

  Notch is building best-in-class T cell therapies.